[1]
“Immunohistochemical Evaluation of CD3+ and CD8+ tumour-Infiltrating Lymphocytes and their Association with Clinicopathological Features in Breast Cancer ”, J. Can. Res. Updates, vol. 15, no. 1, pp. 118–128, May 2026, doi: 10.30683/1929-2279.2026.15.10.